Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Cellular Differentiation00:57

Cellular Differentiation

5.5K
How does a complex organism such as a human develop from a single cell? It all starts from a single fertilized egg which gives rise to a vast array of cell types, such as nerve cells, muscle cells, and epithelial cells that characterize the adult? Throughout development and adulthood, cellular differentiation leads cells to assume their final morphology and physiology. Differentiation is the process by which unspecialized cells become specialized to carry out distinct functions.
A zygote is a...
5.5K
Cellular Respiration01:18

Cellular Respiration

2.1K
Cellular respiration is a crucial metabolic process through which cells obtain energy from organic substances, mainly glucose, to produce adenosine triphosphate (ATP). This process includes the oxidation of substrates and the transfer of electrons to a separate electron acceptor, facilitating ATP synthesis through a sequence of biochemical reactions.Glycolysis: The Initial StepGlycolysis is the first stage of cellular respiration, occurring in the cytoplasm of both prokaryotic and eukaryotic...
2.1K
Introduction to Cellular Respiration01:22

Introduction to Cellular Respiration

189.9K
Organisms harvest energy from food, but this energy cannot be directly used by cells. Cells convert the energy stored in nutrients into a more usable form: adenosine triphosphate (ATP).
ATP stores energy in chemical bonds that can be quickly released when needed. Cells produce energy in the form of ATP through the process of cellular respiration. Although much of the energy from cellular respiration is released as heat, some of it is used to make ATP.
During cellular respiration, several...
189.9K
Cellular Membranes and Drug Transport01:24

Cellular Membranes and Drug Transport

1.6K
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
1.6K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

16.7K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
16.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oxidized mannan-MOG35-55 conjugate as a platform for antigen-specific immune modulation in multiple sclerosis.

Frontiers in immunology·2026
Same author

Correction: Alpha-7 nicotinic acetylcholine receptor: targeting the interplay between inflammation, renin-angiotensin aldosterone system, and nervous system for the novel treatment of heart failure.

Frontiers in pharmacology·2026
Same author

Alpha-7 nicotinic acetylcholine receptor: targeting the interplay between inflammation, renin-angiotensin aldosterone system, and nervous system for the novel treatment of heart failure.

Frontiers in pharmacology·2026
Same author

Pulmonary edema in Dengue: a systematic review and meta-analysis.

Le infezioni in medicina·2026
Same author

Pyridoxal 5'-Phosphate Suppresses Growth of Pancreatic Adenocarcinoma Cells In Vitro via Regulation of Oncogenic RAS.

Molecular nutrition & food research·2026
Same author

Comparison between the new Xpert <i>Mycobacterium tuberculosis/</i>Rifampicin (MTB/RIF) Ultra assay and Xpert MTB/RIF for diagnosis of extra-pulmonary tuberculosis in a tertiary care center.

Microbiology spectrum·2025

Related Experiment Video

Updated: Feb 10, 2026

Using Unfixed, Frozen Tissues to Study Natural Mucin Distribution
11:39

Using Unfixed, Frozen Tissues to Study Natural Mucin Distribution

Published on: September 21, 2012

48.5K

Cellular Mucins: Targets for Immunotherapy.

Vasso Apostolopoulos1, Ian F C McKenzie1

  • 1The Austin Research Institiute, Studley Road, Heidelberg 3084, Victoria, Australia.

Critical Reviews in Immunology
|May 19, 2018
PubMed
Summary
This summary is machine-generated.

Mucin 1 (MUC1) is a promising target for cancer immunotherapy. Research shows MUC1 peptide epitopes can stimulate immune responses, leading to clinical trials for MUC1-based cancer vaccines.

More Related Videos

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

16.0K
Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins
09:24

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins

Published on: June 14, 2016

27.1K

Related Experiment Videos

Last Updated: Feb 10, 2026

Using Unfixed, Frozen Tissues to Study Natural Mucin Distribution
11:39

Using Unfixed, Frozen Tissues to Study Natural Mucin Distribution

Published on: September 21, 2012

48.5K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

16.0K
Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins
09:24

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins

Published on: June 14, 2016

27.1K

Area of Science:

  • Oncology
  • Immunology
  • Biochemistry

Background:

  • Mucins, particularly Mucin 1 (MUC1), are overexpressed and aberrantly glycosylated in various adenocarcinomas, presenting unique epitopes on cancer cell surfaces.
  • These altered MUC1 epitopes, including peptide and carbohydrate neo-antigens, are absent in normal tissues, making them ideal targets for cancer immunotherapy.

Purpose of the Study:

  • To explore the potential of MUC1 as a target for cancer immunotherapy and vaccine development.
  • To investigate the immunogenicity of MUC1 peptide epitopes and their role in stimulating anti-cancer immune responses.

Main Methods:

  • Analysis of MUC1 expression and glycosylation in cancer tissues.
  • Identification and characterization of immunogenic MUC1 peptide epitopes within the variable number tandem repeats (VNTR).
  • In vitro stimulation of human cytotoxic T lymphocytes (CTLs) against MUC1 epitopes.

Main Results:

  • A specific peptide epitope, APDTR, within the MUC1 VNTR, is highly immunogenic in mice and recognized by antibodies against breast cancer.
  • Human breast cancer patients possess precursors of non-MHC restricted CTLs in lymph nodes that can be stimulated to target MUC1 peptide epitopes.
  • Successful development of MUC1-based immunotherapies using synthetic carbohydrates or peptides conjugated with adjuvants.

Conclusions:

  • Mucin 1 (MUC1) presents viable peptide and carbohydrate neo-epitopes for cancer immunotherapy.
  • MUC1-based vaccines are under clinical investigation for their immunogenicity and efficacy against cancers like breast, ovarian, and pancreatic cancer.